The RHAPSODY study is looking at how well new software features work with the Rhythmia Mapping System. This system helps doctors create detailed maps of the heart during procedures for irregular heartbeats (cardiac arrhythmias). You might be able to join if you are 18 or older and are already scheduled for a standard heart mapping procedure using the Rhythmia Mapping System for conditions like atrial fibrillation or ventricular tachycardia. The main goal is for doctors to give feedback on how the new software performs during the procedure. This study is observational, meaning researchers will gather information during your regular care. The current recruitment status is unclear, and the study aims to enroll 100 participants.

Study design

This is an observational study involving 100 participants. It is not specified if it's randomized or blinded.

What's involved

You would participate during your standard-of-care catheter-based endocardial mapping procedure for irregular heartbeats.

Compensation

Not stated in the trial record.

Follow-up

Physician feedback on software performance is measured at 1 day (procedure).

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.